Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Thoracic 1Sarcoma 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Respiratory Tract Diseases 1Papillary renal cell carcinoma, sporadic 1Pancreatic Intraductal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Liver Cirrhosis 1Leiomyosarcoma 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Histiocytoma, Malignant Fibrous 1Hereditary leiomyomatosis and renal cell cancer 1

Interventions

pembrolizumab 139Cisplatin 76Cetuximab 53Carboplatin 50Paclitaxel 40Nivolumab 40Radiotherapy 38Docetaxel 34Radiotherapy, Intensity-Modulated 30Magnetic Resonance Spectroscopy 25Fluorouracil 21Specimen Handling 20Platinum 141,2-diaminocyclohexaneplatinum II citrate 13Taxes 12cemiplimab 11Radiation 11Ipilimumab 11Drug Therapy 11atezolizumab 10Surgical Procedures, Operative 10tislelizumab 9Biopsy 9durvalumab 8Radiosurgery 8Chemoradiotherapy 8Albumin-Bound Paclitaxel 8Standard of Care 7130-nm albumin-bound paclitaxel 7Immune Checkpoint Inhibitors 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Erlotinib Hydrochloride × 1 year × Clear all
NCT00076310 2026-04-15

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT05827614 2026-01-23

POTENTIATE

Boundless Bio, Inc.

Phase 1 Active not recruiting
85 enrolled
BreastHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01927744 2025-11-26

Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

M.D. Anderson Cancer Center

Phase 2 Completed
55 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡